Abstract: A one-handed press-open cosmetic container includes a bottle body assembly and a bottle cap assembly. The bottle cap assembly includes a claw assembly that includes (i) a plurality of clasps and (ii) a button column protruding upward from a top of the claw assembly. The clasps engage with a snap-fit groove of the bottle body assembly. The claw assembly is configured to, upon receiving a downward force from a user's finger via the button column, deform the clasps outward to detach from the snap-fit groove of the bottle body.

Abstract: Disclosed is a mineral exploration system and method within the field of mineral exploration technology. The system comprises a microwave emission module, a Rydberg Atom Antenna, and a signal extraction module, with both the microwave emission module and the signal extraction module being connected to the Rydberg Atom Antenna; the microwave emission module is used to emit probing microwaves into the subsurface, where these microwaves interact with underground structures to generate reflected microwaves; the Rydberg Atom Antenna is employed to receive the reflected microwaves and generate reflected signals based on them; the signal extraction module is tasked with extracting fingerprint signals of the underground structures from the reflected signals.

Abstract: A bridge monitoring method, system, a structure state monitoring device and a storage medium, which comprises: obtaining at least one qubit pair in a quantum entangled state; the coupling relationship between the qubit pair state of at least one qubit pair and the physical parameters of the bridge is constructed. The qubit pair state of at least one qubit pair is monitored, and the structural state of the bridge is determined based on the qubit pair state and the coupling relationship. The invention uses the entanglement relation of quantum bits to realize the real-time monitoring of the bridge structure state in the full range of the bridge with high sensitivity and high resolution.

Abstract: A one-handed press-open cosmetic container includes a bottle body assembly and a cap assembly, and the cap assembly is fixed to the snap-fit groove of the bottle neck by the clasps of the claws in the cap assembly; wherein the cap assembly includes an outer and inner cap and claws, wherein the clasps are equally spaced and L-shaped, disposed down inwardly, and the ends are provided with inwardly humped heads, the clasps are respectively snapped into the clasp holes at the top corners of the inner cap, and securely snap-fit to the snap-fit groove through the clasp head, the top center of the resilient disc surface of the claws includes an upwardly humped button column, which extends from or is disposed in the center hole of the outer cap, when a force is applied, the claws drive the clasp head to open outwardly until it detaches from the snap ring.

Abstract: The present disclosure discloses a pad-steam bleaching method based on a TBLC-activated hydrogen peroxide system, and belongs to the field of pretreatment processing of textiles. According to the pad-steam bleaching method based on the TBLC-activated hydrogen peroxide system, TBCC and H2O2 are compounded with a weak base to prepare a TBCC/H2O2/weak base system for performing near-neutral bleaching on cotton fabrics; the fabrics are padded and then steamed to be bleached. By the method disclosed by the present disclosure, the whiteness of fabric treated for 2 minutes by a TBCC/H2O2/sodium citrate padding and steaming system is significantly superior to that of fabric treated for 60 minutes by an H2O2/NaOH dip bleaching system. The CIE whiteness of the fabric reaches 77 and above, the fabric wettability after treatment is also improved, the damage of the fabric is smaller, and the amount of water used by the method is small.

Abstract: The present invention provides novel compounds of Formula (I), and pharmaceutically acceptable salts, solvates, hydrates, polymorphs, co-crystals, tautomers, stereoisomers, isotopically labeled derivatives, prodrugs, and compositions thereof. Also provided are methods and kits involving the compounds of Formula (I) or (II), or compositions thereof, for treating or preventing a wide range of diseases (e.g., proliferative diseases (e.g., cancers, benign neoplasms, angiogenesis, inflammatory diseases, autoimmune diseases) and metabolic diseases (e.g., diabetes (e.g., type 2 diabetes, gestational diabetes)) in a subject. Treatment of a subject with a disease using a compound of Formula (I) or (II), or compositions thereof, may downregulate the expression and/or inhibit the activity of a kinase (e.g., a tyrosine kinase, such as a Tec kinase, in particular, bone marrow on X chromosome kinase (BMX)), and therefore, suppress tyrosine kinase singling in the subject.

Abstract: The present disclosure discloses a pad-steam bleaching method based on a TBLC-activated hydrogen peroxide system, and belongs to the field of pretreatment processing of textiles. According to the pad-steam bleaching method based on the TBLC-activated hydrogen peroxide system, TBCC and H2O2 are compounded with a weak base to prepare a TBCC/H2O2/weak base system for performing near-neutral bleaching on cotton fabrics; the fabrics are padded and then steamed to be bleached. By the method disclosed by the present disclosure, the whiteness of fabric treated for 2 minutes by a TBCC/H2O2/sodium citrate padding and steaming system is significantly superior to that of fabric treated for 60 minutes by an H2O2/NaOH dip bleaching system. The CIE whiteness of the fabric reaches 77 and above, the fabric wettability after treatment is also improved, the damage of the fabric is smaller, and the amount of water used by the method is small.

Abstract: The present invention provides novel compounds of Formula (I), and pharmaceutically acceptable salts, solvates, hydrates, polymorphs, co-crystals, tautomers, stereoisomers, isotopically labeled derivatives, prodrugs, and compositions thereof. Also provided are methods and kits involving the compounds of Formula (I) or (II), or compositions thereof, for treating or preventing a wide range of diseases (e.g., proliferative diseases (e.g., cancers, benign neoplasms, angiogenesis, inflammatory diseases, autoimmune diseases) and metabolic diseases (e.g., diabetes (e.g., type 2 diabetes, gestational diabetes)) in a subject. Treatment of a subject with a disease using a compound of Formula (I) or (II), or compositions thereof, may downregulate the expression and/or inhibit the activity of a kinase (e.g., a tyrosine kinase, such as a Tec kinase, in particular, bone marrow on X chromosome kinase (BMX)), and therefore, suppress tyrosine kinase singling in the subject.

Abstract: The present invention provides novel compounds of Formula (I), and pharmaceutically acceptable salts, solvates, hydrates, polymorphs, co-crystals, tautomers, stereoisomers, isotopically labeled derivatives, prodrugs, and compositions thereof. Also provided are methods and kits involving the compounds of Formula (I) or (II), or compositions thereof, for treating or preventing a wide range of diseases (e.g., proliferative diseases (e.g., cancers, benign neoplasms, angiogenesis, inflammatory diseases, autoimmune diseases) and metabolic diseases (e.g., diabetes (e.g., type 2 diabetes, gestational diabetes)) in a subject. Treatment of a subject with a disease using a compound of Formula (I) or (II), or compositions thereof, may downregulate the expression and/or inhibit the activity of a kinase (e.g., a tyrosine kinase, such as a Tec kinase, in particular, bone marrow on X chromosome kinase (BMX)), and therefore, suppress tyrosine kinase singling in the subject.

Abstract: The present invention provides novel compounds of Formula (I), and pharmaceutically acceptable salts, solvates, hydrates, polymorphs, co-crystals, tautomers, stereoisomers, isotopically labeled derivatives, prodrugs, and compositions thereof. Also provided are methods and kits involving the compounds of Formula (I) or (II), or compositions thereof, for treating or preventing a wide range of diseases (e.g., proliferative diseases (e.g., cancers, benign neoplasms, angiogenesis, inflammatory diseases, autoimmune diseases) and metabolic diseases (e.g., diabetes (e.g., type 2 diabetes, gestational diabetes)) in a subject. Treatment of a subject with a disease using a compound of Formula (I) or (II), or compositions thereof, may downregulate the expression and/or inhibit the activity of a kinase (e.g., a tyrosine kinase, such as a Tec kinase, in particular, bone marrow on X chromosome kinase (BMX)), and therefore, suppress tyrosine kinase singling in the subject.

Abstract: The invention relates to an iron comprising a cartridge (4) for containing a liquid (5), a nozzle means (6) having at least one aperture (20), a pump means (14) for delivering said liquid to the nozzle means, said cartridge (4) comprising an outer wall (29) with vent means (25) including a vent hole (28) for ventilating said cartridge (4). To prevent soiling of the iron due to spillage of liquid (5) through the vent hole (28), said vent means (25) comprises a storage chamber (26) for receiving an excess of liquid from the cartridge.

Abstract: The present invention discloses a multi-function roulette apparatus that comprises a base, a shaft, a combination block, a rotation structure and a fixing device. The roulette apparatus has the design of counters placing space that is convenient for the players to take the counters. The rotating structure, combination block and fixing device are combined spirally that can prevent the roulette apparatus from falling off while moving and achieve the result of portability.